2015 HB 269 “Florida Right to Try Act” to Ease Restrictions on Experimental Treatments for Terminally-ill

CS/CS/HB 269 – Experimental Treatments for Terminal Conditions

General Bill   by Insurance & Banking Subcommittee and Health Innovation Subcommittee and Pilon (CO-SPONSORS) Harrison; Magar

Experimental Treatments for Terminal Conditions: Provides conditions for manufacturer to provide certain drugs, products, or devices to eligible patient; specifies insurance coverage requirements & exceptions; provides conditions for provision of certain services by hospital or health care facility; provides immunity from liability; provides protection from disciplinary or legal action against physician who makes certain treatment recommendations; provides that cause of action may not be asserted against manufacturer of certain drugs, products, or devices or person or entity caring for patient using such drug, product, or device under certain circumstances; provides applicability.

Effective Date: July 1, 2015

Last Event: Added to Second Reading Calendar on Wednesday, April 01, 2015 3:20 PM

Follow HB 269  Read CS/CS/HB 269

Related bill: CS/SB 1052 – Florida Right to Try Act

As of 04/01/2015, this bill has been reported as “Favorable” by the Health Innovation Subcommittee, the Insurance and Banking Subcommittee, and the Health & Human Services Committee.


Florida House Subcommittee Approves Bill to Block Some FDA Restrictions on Terminally-ill